Stockscreener 앱 받기
3.00
13.29%
-0.46
시간 외 거래:
3.00
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Quantum BioPharma Takes a Bold Step into Cryptocurrency! This Could Change Everything! - YaNoticias
Biopharmaceutical company Quantum BioPharma reveals it bought $1 million worth of cryptocurrency - PANews
Quantum BioPharma Secures $500K in Fresh Capital Through Second Tranche Offering - StockTitan
Quantum Biopharma Announces Closing of Second Tranche - AccessWire
Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing - crypto.news
Quantum BioPharma Invests $1 Million in Bitcoin - PortalCripto
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency - Milton Daily Standard
Quantum BioPharma Makes Bold $1M Bitcoin Investment, Embraces Crypto for Future Transactions - StockTitan
Quantum BioPharma Diversifies Treasury with the Purchase of - GlobeNewswire
Quantum BioPharma Makes Bold $1M Strategic Investment in Bitcoin, Crypto Assets - StockTitan
QNTM stock touches 52-week low at $3.48 amid market fluctuations - Investing.com Australia
How This $4 Stock is Taking on Wall Street's Big Banks with a $700 Million Lawsuit - Asianet Newsable
Quantum BioPharma Ltd. and HUGE Biopharma Australia Pty Ltd Announces the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - Marketscreener.com
Quantum BioPharma Closes First Tranche of Debenture Offering, Raises CAD $500,000 in Fresh Capital - StockTitan
Quantum Biopharma Announces Closing of First Tranche - AccessWire
Quantum BioPharma progresses with drug trial dosing By Investing.com - Investing.com South Africa
Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma - The Eastern Progress Online
Quantum Biopharma Ltd (QNTM-Q) QuotePress Release - The Globe and Mail
Quantum BioPharma progresses with drug trial dosing - Investing.com
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - AccessWire
Quantum BioPharma Advances Phase 1 Trial After Positive Safety Review of Novel Drug Candidate - StockTitan
Quantum BioPharma announces convertible debenture offering By Investing.com - Investing.com Nigeria
Quantum BioPharma Launches $5 Million Private Placement - TipRanks
Quantum BioPharma announces convertible debenture offering - Investing.com
Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million - AccessWire
Quantum BioPharma Ltd. announced that it expects to receive CAD 5 million in funding - Marketscreener.com
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Allege - Galveston County Daily News
Quantum BioPharma Files $700M Lawsuit Against CIBC, RBC Over Market Manipulation - StockTitan
Quantum BioPharma Ltd expected to post a loss of $3.90 a shareEarnings Preview - XM
Quantum BioPharma initiates phase 1 multiple sclerosis trial By Investing.com - Investing.com Canada
Quantum BioPharma sues CIBC and RBC seeking $700M in damages - MSN
Quantum BioPharma initiates phase 1 multiple sclerosis trial - Investing.com
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - AccessWire
InvestmentPitch Media Video Discusses FSD Pharma's New OTCQB Symbol and Appointment of Former U.S. Congressman Stephen Buyer to its Board of DirectorsVideo Available on Investmentpitch.com - Marketscreener.com
Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma - Marketscreener.com
Quantum BioPharma Ltd - Stockhouse Publishing
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH - Marketscreener.com
Quantum BioPharma posts link to lawsuit against CIBC World Markets, RBC Dominion - TipRanks
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spo - AccessWire
Quantum BioPharma alleges major market manipulation By Investing.com - Investing.com Australia
Quantum BioPharma sues over alleged stock spoofing - The Globe and Mail
Quantum BioPharma sues CIBC and RBC seeking $700M in damages | 2024-10-21 | Investing News - Stockhouse Publishing
Quantum BioPharma alleges major market manipulation - Investing.com
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Chronicle-Tribune
Quantum BioPharma (QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700M - StreetInsider.com
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd - openPR
Kairos Pharma (NYSEAmerican: KAPA): Advancing New Strategies to Overcome Cancer Treatment Challenges - openPR
Quantum BioPharma Expands Market for Alcohol Metabolism Product Unbuzzd - Citybuzz
Celly Nu secures distribution for alcohol metabolism drink By Investing.com - Investing.com South Africa
Celly Nu secures distribution deal in the Caribbean By Investing.com - Investing.com South Africa
Celly Nu secures distribution deal in the Caribbean - Investing.com India
Celly Nu secures distribution for alcohol metabolism drink - Investing.com
1.61%
1.65%
자본화:
|
볼륨(24시간):